The U.S. Food and Drug Administration (FDA) emergency use authorization of three vaccines, all which have shown greater than 85% effectiveness against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (1–3), has provided the public with hope ending global COVID-19 pandemic. However, recent outbreaks more transmissible variant SARS-CoV-2 strains that harbor mutations in spike protein—...